From 1 October 2021 the Australian Government announced people aged 60 and over can access any brand of COVID-19 vaccine, including the Comirnaty (Pfizer) or Spikevax (Moderna) vaccines, at all vaccination sites, regardless of where they live.
people aged 18+ can access any COVID-19 vaccine (Pfizer, Moderna and Vaxzevria (AstraZeneca)); and
people aged 12+ can access the Moderna or Pfizer vaccines.
It is important that high priority and vulnerable cohorts continue to be prioritised for vaccination appointments where possible, such as home care workers, disability support workers and Aboriginal and Torres Strait Islander people, to access a COVID-19 vaccine. See Department of Health statement.
Invalid COVID-19 vaccine doses
New ATAGI clinical guidance is available on the use of an additional COVID-19 vaccine dose as a replacement dose for an invalid dose in specified scenarios of schedule deviation or vaccine administration errors, including:
Giving a replacement dose if a second COVID-19 vaccine dose was given at less than 14 days after the first dose
Giving a replacement dose for specified vaccine administration errors resulting in under-dosing
This clinical guidance does not pertain to recommendations for a third or booster dose after completion of the valid two-dose primary course according to an acceptable schedule.
Temporary medical exemptions for COVID-19 vaccines
There are very few situations where a vaccine is contraindicated and as such, medical exemption is expected to be rarely required. ATAGI have developed guidance for providers on acute major medical conditions that warrant a temporary medical exemption relevant for COVID-19 vaccines.
Temporary medical exemptions can only be completed by eligible health professionals utilising their Medicare provider number, and can be recorded on the Australian Immunisation Register (AIR) either by:
An AIR Immunisation History Statement displays all vaccinations or medical contraindications and authorised exemptions, including COVID-19, that have been reported to the Australian Immunisation Register. There is no longer any need to use the NSW Health Medical Contraindication form.
Recognition of overseas COVID-19 vaccines
Following assessment to determine the protection offered by vaccines against infection and serious illness, TGA’s initial advice is that Coronavac (Sinovac) and Covishield (AstraZeneca/Serum Institute of India) vaccines be considered ‘recognised vaccines’ for incoming international travellers to be regarded as appropriately vaccinated.
COVID-19 vaccines which have been granted provisional approval in Australia – Pfizer (Comirnaty), AstraZeneca (Vaxzevria), Moderna (Spikevax) and COVID-19 Vaccine Janssen are also recognised for incoming travellers.
At this point in time, TGA has received insufficient data to reach a conclusion as to the protection offered by BIBP-CorV (Sinopharm), Covaxin (Bharat Biotech), Sputnik V (Gamaleya Institute), and Convidecia (CanSino). These vaccines could be recognised in the coming weeks or months as more data becomes available. See TGA statement.
Children and COVID-19 FAQs
Children aged 12 years and older are recommended to get COVID-19 vaccine and the vaccination program for this age group is underway in Australia. NCIRS has answered some of the most frequently asked questions about COVID-19 in children, vaccines available in Australia, vaccine safety and schooling. The FAQs are available on the NCIRS website.
COVID-19 vaccine safety data for people aged 12 to 19
New COVID-19 vaccine safety data from AusVaxSafety has shown adolescents aged 12–19 years are reporting similar short-term vaccine side effects to those reported by older Australians. AusVaxSafety has received more than 150,000 completed day 3 safety surveys from adolescents aged 12–19 years who received their COVID-19 vaccine and to date, the data analysis has not detected any safety signals for this age group.
Authentication file access to the Australian Immunisation Register (AIR) closed on 30 September 2021 for all providers. A Provider Digital Access (PRODA) account is required to access the AIR via the Health Professionals Online Services (HPOS) portal from this date onward. Instructions for health professionals and medical practices to set up AIR access can be found here.
COVID-19 live stream update for GPs
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments!
Register here for upcoming NCIRS webinar: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety. Consider the risks and benefits of COVID-19 vaccination and learn strategies for discussions to support your patients, friends and family in making decisions.
Date and time: Wednesday 13 October 2021, 12.30 pm – 2.00 pm AEDT
Speak up for the community: Do you know someone who could give great input about health needs and services? voices4health is the place where people living in central and eastern Sydney can contribute to decision-making about health needs and services in the area where they live. This is a place…
Voices4Health – have your say about health services in your area Are you interested in having a say about health needs and health services in your area? voices4health is the place where people living in central and eastern Sydney can contribute to decision-making about health needs and services in the…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. General Manager First Nations Fashion + Design and Wiradjuri Woman living on Dharawal Country Emma Griggs (pictured below at the recent Australian Fashion Week 2023 at Carriageworks, Gadigal land), shared this: 1. What did…
Mandarin and Cantonese Diabetes Workshops: Diabetes NSW & ACT have FREE upcoming workshops delivered in Mandarin and Cantonese. We know small, healthy lifestyle decisions can lead to great improvements in health, and can prevent or delay the onset of complications associated with diabetes. Participants will learn about: Understanding diabetes Making…
Chronic obstructive pulmonary disease Trial Invitation for General Practices Calling General Practices to Participate in the Activating Primary Care COPD (Chronic obstructive pulmonary disease) Patients with Multimorbidity (APCOM) trial. The trial aims to implement and evaluate an innovative tailored, self-management support program, delivered by Practice Nurses to people with COPD…
Introducing the RPA Virtual Fracture Clinic The Virtual Fracture Clinic at RPA Virtual Hospital is a physiotherapy-led service using videocalls to manage patients with clinically & radiologically diagnosed simple fractures. This publicly funded free service provides accessible care for patients to reduce unnecessary emergency department and in-person fracture clinic presentations….